Literature DB >> 8277082

Three-dimensional reconstruction of ventricular septal defects: validation studies and in vivo feasibility.

J M Rivera1, S C Siu, M D Handschumacher, J P Lethor, J L Guerrero, G J Vlahakes, J D Mitchell, A E Weyman, M E King, R A Levine.   

Abstract

OBJECTIVES: The purpose of this study was to demonstrate the feasibility of in vivo three-dimensional reconstruction of ventricular septal defects and to validate its quantitative accuracy for defect localization in excised hearts (used to permit comparison of three-dimensional and direct measurements without cardiac contraction).
BACKGROUND: Appreciating the three-dimensional spatial relations of ventricular septal defects could be useful in planning surgical and catheter approaches. Currently, however, echocardiography provides only two-dimensional views, requiring mental integration. A recently developed system automatically combines two-dimensional echocardiographic images with their spatial locations to produce a three-dimensional construct.
METHODS: Surgically created ventricular septal defects of varying size and location were imaged and reconstructed, along with the left and right ventricles, in the beating heart of six dogs to demonstrate the in vivo feasibility of producing a coherent image of the defect that portrays its relation to surrounding structures. Two additional gel-filled excised hearts with defects were completely reconstructed. Quantitative localization of the defects relative to other structures (ventricular apexes and valve insertions) was then validated for seven defects in excised hearts. The right septal margins of the exposed defects were also traced and compared with their reconstructed areas and circumferences.
RESULTS: The three-dimensional images provided coherent images and correct spatial appreciation of the defects (two inlet, two trabecular, one outlet and one membranous Gerbode in vivo; one inlet and one apical in excised hearts). The distances between defects and other structures in the excised hearts agreed well with direct measures (y = 1.05x-0.18, r = 0.98, SEE = 0.30 cm), as did reconstructed areas (y = 1.0x-0.23, r = 0.98, SEE = 0.21 cm2) and circumferences (y = 0.97x + 0.13, r = 0.97, SEE = 0.3 cm).
CONCLUSIONS: Three-dimensional reconstruction of ventricular septal defects can be achieved in the beating heart and provides an accurate appreciation of defect size and location that could be of value in planning interventions.

Entities:  

Mesh:

Year:  1994        PMID: 8277082     DOI: 10.1016/0735-1097(94)90521-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  6 in total

Review 1.  Developments in cardiovascular ultrasound. Part 3: Cardiac applications.

Authors:  C M Moran; W N McDicken; P R Hoskins; P J Fish
Journal:  Med Biol Eng Comput       Date:  1998-09       Impact factor: 2.602

2.  Three dimensional reconstruction of the heart with rotational acquisition: methods and clinical applications.

Authors:  A Salustri; J Roelandt
Journal:  Br Heart J       Date:  1995-05

3.  Three-dimensional echocardiographic assessment of acquired left ventricular to right atrial shunt (Gerbode defect).

Authors:  Kibar Yared; Jorge Solis; Jonathan Passeri; Mary Etta E King; Robert A Levine
Journal:  J Am Soc Echocardiogr       Date:  2009-02-08       Impact factor: 5.251

4.  Three-dimensional echocardiography of ventricular septal defects.

Authors:  M Hoch; U Roemer; R Kozlik-Feldmann; A Fuchs; H Netz
Journal:  Images Paediatr Cardiol       Date:  2002-07

5.  An Acoustic Tracking Approach for Medical Ultrasound Image Simulator.

Authors:  Po-Heng Chen; Kai-Sheng Hsieh; Chih-Chung Huang
Journal:  J Med Biol Eng       Date:  2017-06-21       Impact factor: 1.553

6.  Experimental 3-D Ultrasound Imaging with 2-D Sparse Arrays using Focused and Diverging Waves.

Authors:  Emmanuel Roux; François Varray; Lorena Petrusca; Christian Cachard; Piero Tortoli; Hervé Liebgott
Journal:  Sci Rep       Date:  2018-06-14       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.